Format

Send to

Choose Destination
Blood. 2016 Oct 20;128(16):2089-2092. doi: 10.1182/blood-2016-04-710160. Epub 2016 Sep 1.

A novel TERC CR4/CR5 domain mutation causes telomere disease via decreased TERT binding.

Author information

1
Division of Hematology/Oncology and Stem Cell Program, Boston Children's Hospital, Boston, MA.
2
Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
3
Harvard Stem Cell Institute, Boston, MA.
4
Department of Pediatrics, Harvard Medical School, Boston, MA.
5
Department of Basic Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
6
New York Oncology Hematology, Albany Medical Center, Albany, NY.
7
Department of Pathology, Boston Children's Hospital, Boston, MA; and.
8
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
PMID:
27587879
PMCID:
PMC5073186
DOI:
10.1182/blood-2016-04-710160
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center